SCHEMBL16169011

SCHEMBL16169011

CC(C)[C@H](N)c1ccc(F)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 1/20 0.39
▸ CES1 P23141 1/20 0.39
▸ DPP4 P27487 3/20 0.38
▸ ADRB2 P07550 1/20 0.37
▸ PDPK1 O15530 1/20 0.36
▸ AKR1C3 P42330 1/20 0.35
▸ AKR1C2 P52895 1/20 0.35
▸ APP P05067 1/20 0.35
▸ MME P08473 1/20 0.35
▸ DPP9 Q86TI2 1/20 0.35
▸ DPP7 Q9UHL4 1/20 0.35
▸ RECQL P46063 4/20 0.34
▸ TDP1 Q9NUW8 4/20 0.34
▸ KDM4E B2RXH2 4/20 0.34
▸ MAPT P10636 3/20 0.34
▸ LMNA P02545 2/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ THPO P40225 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14100327 1.00 CES2 (0.39) CES2CES1DPP4ADRB2PDPK1
SCHEMBL5659719 0.83 CES2 (0.44) CES2CES1DPP4ADRB2PDPK1
SCHEMBL14587412 0.83 CES2 (0.44) CES2CES1DPP4ADRB2PDPK1
SCHEMBL4337552 0.83 CES2 (0.44) CES2CES1DPP4ADRB2PDPK1
SCHEMBL1556272 0.83 AKR1C3 (0.43) AKR1C3AKR1C2RECQLTDP1KDM4E
SCHEMBL1240557 0.82 ADRB2 (0.50) CES2CES1DPP4ADRB2PDPK1
SCHEMBL1585297 0.82 ADRB2 (0.50) CES2CES1DPP4ADRB2PDPK1
SCHEMBL7785721 0.82 ADRB2 (0.50) CES2CES1DPP4ADRB2PDPK1
SCHEMBL1556537 0.82 APP (0.39) ADRB2APP
Hydrochloric Acid SCHEMBL4345264 0.82 CES2 (0.43) CES2CES1DPP4PDPK1AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051310-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2015-06-09 — — US disclosed
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2014-10-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, BTK, NOX4 CES2 4022/4885CES1 1754/4885DPP4 735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback